|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 19/10 | (2006.01) |
| C07F 9/24 | (2013.01) | ||
| C07H 1/00 | (2006.01) | ||
| C07H 1/02 | (2013.01) | ||
| C07F 9/24 | (2006.01) | ||
| C07H 19/10 | (2013.01) | ||
| C07H 1/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3351551 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16845696.0 |
| Date of filing the European patent application | 2016-09-13 | |
| (97) | Date of publication of the European application | 2018-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2016/098846 |
| Date | 2016-09-13 |
| (87) | Number | WO 2017/045582 |
| Date | 2017-03-23 |
| (30) | Number | Date | Country code |
| 201510588122 | 2015-09-16 | CN |
| (72) |
YUAN, Jiandong , CN
HUANG, Yangqing , CN
MIAO, Linfeng , CN
GU, Jianing , CN
LIANG, Chaohua , CN
WANG, Zhengye , CN
SUN, Zhanli , CN
|
| (73) |
BrightGene Bio-Medical Technology Co., Ltd. ,
Building C25
No. 218 Xinghu Street, BioBay, Suzhou Industrial Park
Suzhou Jiangsu 215123,
CN
|
| (54) | PREPARATION METHOD OF NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS AND INTERMEDIATES THEREOF |
| PREPARATION METHOD OF NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS AND INTERMEDIATES THEREOF |